Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Life Sciences|April 14, 2024
Enhancing cancer therapy: The role of drug delivery systems in STAT3 inhibitor efficacy and safetyKang-Ning Wang, Kan Zhou, Nian-Nian Zhong, et al.
Oral Oncology|June 13, 2025
Postoperative complications of neck dissection for head and neck squamous cell carcinoma: a systematic review and meta-analysisChon-Hou Mak, Lei-Ming Cao, Han-Yue Luo, et al.
Oncoimmunology|April 11, 2018
Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinomaLei Wu, Guang-Tao Yu, Wei-Wei Deng, et al.
Medcomm|March 31, 2022
STAT3 pathway in cancers: Past, present, and futureHan-Qi Wang, Qi-Wen Man, Fang-Yi Huo, et al.
Head & Neck|November 29, 2024
Complications in Deep Circumflex Iliac Artery-Related Vascularized Free Iliac FlapBin Zhang, Yu-Zhong Qiu, Lei-Ming Cao, et al.
ACS Applied Materials & Interfaces|January 5, 2017
Erythrocyte Membrane-Coated Upconversion Nanoparticles with Minimal Protein Adsorption for Enhanced Tumor ImagingLang Rao, Qian-Fang Meng, Lin-Lin Bu, et al.
Journal of Nanobiotechnology|March 30, 2024
Revolutionizing lymph node metastasis imaging: the role of drug delivery systems and future perspectivesZe-Min Cai, Zi-Zhan Li, Nian-Nian Zhong, et al.
Oncoimmunology|July 29, 2016
Targeting STAT3 signaling reduces immunosuppressive myeloid cells in head and neck squamous cell carcinomaLin-Lin Bu, Guang-Tao Yu, Wei-Wei Deng, et al.
Molecular Oncology|January 20, 2017
T-cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancerJian-Feng Liu, Si-Rui Ma, Liang Mao, et al.
Materials Today. Bio|January 29, 2026
Emerging roles of microfluidics in oral cancer research and clinical translationZi-Zhan Li, Li-Ya Wei, Lei-Ming Cao, et al.
Pageof 12